EMA Authorised: Yselty (linzagolix choline) — Theramex Ireland Limited

View source ↗

Summary

EMA authorised Yselty (linzagolix choline) for uterine fibroids (leiomyoma); Theramex Ireland Limited is the marketing authorisation holder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Yselty (linzagolix choline)

Snippet

Status: Authorised. Therapeutic area: Leiomyoma. MAH: Theramex Ireland Limited. Decision date: 22/11/2024